Abstract
A phagocytosis assay was used to measure the prevalence of cytophilic antibodies directed against Plasmodium falciparum merozoites in three groups of subjects from Africa: preimmune (individuals aged 2 to 15 years), immune (adults), and postimmune (African adults residing out of the endemic area). Results show that levels of antibodies promoting merozoite phagocytosis (APMP) increase slowly and gradually with age. The production of high levels of APMP requires about 15 years of continuous exposure to malaria and concurs with the ability of exposed individuals to control a high parasitemia and its pathological consequences, such as spleen enlargement. In the absence of antigenic restimulation for more than 1 year (postimmune subjects), APMP titers decrease abruptly. No correlation was found between APMP levels and levels of antimalarial antibodies detected by fluorescence and precipitation assays. Low levels of APMP in subjects susceptible to clinical manifestations of the disease and high levels in subjects in a state of premunition suggest that the results of the merozoite phagocytosis assay more closely reflect clinical immunity than do other markers of antimalarial humoral immunity.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Ballet J. J., Druilhe P., Vasconcelos I., Schmitt C., Agrapart M., Frommel D. Human lymphocyte responses to Plasmodium falciparum merozoite antigens. A functional assay of protective immunity? Trans R Soc Trop Med Hyg. 1985;79(4):497–499. doi: 10.1016/0035-9203(85)90076-8. [DOI] [PubMed] [Google Scholar]
- DAVIDSON G. Further studies of the basic factors concerned in the transmission of malaria. Trans R Soc Trop Med Hyg. 1955 Jul;49(4):339–350. doi: 10.1016/0035-9203(55)90056-0. [DOI] [PubMed] [Google Scholar]
- Druilhe P., Monjour L., Richard-Lenoble D., Gentilini M. L'immuno-électro-diffusion sur membrane d'acétate de cellulose pour le diagnostic sérologique du paludisme humain. Pathol Biol (Paris) 1978 Mar-Apr;26(3-4):169–172. [PubMed] [Google Scholar]
- Edington G. M. Pathology of malaria in West Africa. Br Med J. 1967 Mar 25;1(5542):715–718. doi: 10.1136/bmj.1.5542.715. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hommel M. Malaria: immunity and prospects for vaccination. West J Med. 1981 Oct;135(4):285–299. [PMC free article] [PubMed] [Google Scholar]
- Khusmith S., Druilhe P. Antibody-dependent ingestion of P. falciparum merozoites by human blood monocytes. Parasite Immunol. 1983 Jul;5(4):357–368. doi: 10.1111/j.1365-3024.1983.tb00751.x. [DOI] [PubMed] [Google Scholar]
- Khusmith S., Druilhe P. Cooperation between antibodies and monocytes that inhibit in vitro proliferation of Plasmodium falciparum. Infect Immun. 1983 Jul;41(1):219–223. doi: 10.1128/iai.41.1.219-223.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Khusmith S., Druilhe P., Gentilini M. Enhanced Plasmodium falciparum merozoite phagocytosis by monocytes from immune individuals. Infect Immun. 1982 Mar;35(3):874–879. doi: 10.1128/iai.35.3.874-879.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
- McGregor I. A. Immunity to plasmodial infections; consideration of factors relevant to malaria in man. Int Rev Trop Med. 1971;4:1–52. [PubMed] [Google Scholar]
- WILSON D. B., GARNHAM P. C. C., SWELLENGREBEL N. H. A review of hyperendemic malaria. Trop Dis Bull. 1950 Aug;47(8):677–698. [PubMed] [Google Scholar]
- Wahlgren M., Björkman A., Perlmann H., Berzins K., Perlmann P. Anti-Plasmodium falciparum antibodies acquired by residents in a holoendemic area of Liberia during development of clinical immunity. Am J Trop Med Hyg. 1986 Jan;35(1):22–29. doi: 10.4269/ajtmh.1986.35.22. [DOI] [PubMed] [Google Scholar]